420 related articles for article (PubMed ID: 28917495)
1. Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR
Gleva MJ; Wang Y; Curtis JP; Berul CI; Huddleston CB; Poole JE
Am J Cardiol; 2017 Nov; 120(10):1891-1898. PubMed ID: 28917495
[TBL] [Abstract][Full Text] [Related]
2. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry.
Jordan CP; Freedenberg V; Wang Y; Curtis JP; Gleva MJ; Berul CI
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1092-100. PubMed ID: 25287482
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and Outcomes of Pediatric Patients Who Undergo Placement of Implantable Cardioverter Defibrillators: Insights From the National Cardiovascular Data Registry.
Baskar S; Bao H; Minges KE; Spar DS; Czosek RJ
Circ Arrhythm Electrophysiol; 2018 Sep; 11(9):e006542. PubMed ID: 30354291
[TBL] [Abstract][Full Text] [Related]
5. Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States.
Margolis G; Hamuda N; Kobo O; Elbaz Greener G; Amir O; Homoud M; Madias C; Heist EK; Ruskin JN; Kazatsker M; Roguin A; Leshem E; Rozen G
J Am Heart Assoc; 2023 Aug; 12(15):e029126. PubMed ID: 37522389
[TBL] [Abstract][Full Text] [Related]
6. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
[TBL] [Abstract][Full Text] [Related]
7. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of adult patients with congenital heart disease and an implantable cardioverter defibrillator.
Coutinho Cruz M; Viveiros Monteiro A; Portugal G; Laranjo S; Lousinha A; Valente B; Osório P; Silva Cunha P; de Sousa L; Oliveira JA; Agapito A; Martins Oliveira M; Pinto F; Cruz Ferreira R
Congenit Heart Dis; 2019 Jul; 14(4):525-533. PubMed ID: 30889316
[TBL] [Abstract][Full Text] [Related]
9. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
[TBL] [Abstract][Full Text] [Related]
10. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).
Russo AM; Daugherty SL; Masoudi FA; Wang Y; Curtis J; Lampert R
Am Heart J; 2015 Aug; 170(2):330-8. PubMed ID: 26299231
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
[TBL] [Abstract][Full Text] [Related]
12. Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease.
Moore JP; Mondésert B; Lloyd MS; Cook SC; Zaidi AN; Pass RH; John AS; Fish FA; Shannon KM; Aboulhosn JA; Khairy P;
Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635073
[TBL] [Abstract][Full Text] [Related]
13. Device complications in adult congenital heart disease.
Hayward RM; Dewland TA; Moyers B; Vittinghoff E; Tanel RE; Marcus GM; Tseng ZH
Heart Rhythm; 2015 Feb; 12(2):338-44. PubMed ID: 25460176
[TBL] [Abstract][Full Text] [Related]
14. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
[TBL] [Abstract][Full Text] [Related]
15. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
[TBL] [Abstract][Full Text] [Related]
16. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease.
Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA
Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillator therapy to reduce sudden cardiac death in adults with congenital heart disease: A registry study.
Slater TA; Cupido B; Parry H; Drozd M; Blackburn ME; Hares D; Pepper CB; Birkitt L; Cullington D; Witte KK; Oliver J; English KM; Sengupta A
J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2086-2092. PubMed ID: 32583559
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
[TBL] [Abstract][Full Text] [Related]
19. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
[TBL] [Abstract][Full Text] [Related]
20. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.
Kaiser DW; Tsai V; Heidenreich PA; Goldstein MK; Wang Y; Curtis J; Turakhia MP;
Heart Rhythm; 2015 Oct; 12(10):2086-93. PubMed ID: 25982720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]